Sep 2021 News More research is needed about rel-2-((1R,3r,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4-fluorobenzo[d]thiazole-6-carboxylic acid

If you are hungry for even more, make sure to check my other article about 1383816-29-2. Electric Literature of 1383816-29-2

Electric Literature of 1383816-29-2. Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments.Introducing a new discovery about 1383816-29-2, Name is rel-2-((1R,3r,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4-fluorobenzo[d]thiazole-6-carboxylic acid

The present invention relates to a pharmaceutical composition for oral administration comprising a non-bile farnesoid X receptor (FXR) agonist 2-[(1R,3R,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid, or a pharmaceutically acceptable salt thereof, and at least one lipid excipient; to a capsule for oral administration comprising said pharmaceutical composition; to the use of said pharmaceutical composition for the treatment of a FXR mediated disorder or condition; and to a process for preparing said pharmaceutical composition.

If you are hungry for even more, make sure to check my other article about 1383816-29-2. Electric Literature of 1383816-29-2

Reference:
Thiazole | C3H9023NS – PubChem,
Thiazole | chemical compound | Britannica

Brief introduction of 1383816-29-2

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.COA of Formula: C29H25F4N3O5S. In my other articles, you can also check out more blogs about 1383816-29-2

Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments.Introducing a new discovery about 1383816-29-2, Name is rel-2-((1R,3r,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4-fluorobenzo[d]thiazole-6-carboxylic acid, COA of Formula: C29H25F4N3O5S.

COMPOSITIONS AND METHODS FOR MODULATING FXR

The present invention relates to compounds of Formula (I), a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; wherein variables are as defined herein; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesiod X receptors (FXR).

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.COA of Formula: C29H25F4N3O5S. In my other articles, you can also check out more blogs about 1383816-29-2

Reference:
Thiazole | C3H9022NS – PubChem,
Thiazole | chemical compound | Britannica

Downstream synthetic route of 1383816-29-2

The synthetic route of 1383816-29-2 has been constantly updated, and we look forward to future research findings.

1383816-29-2, rel-2-((1R,3r,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4-fluorobenzo[d]thiazole-6-carboxylic acid is a thiazole compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

The previously described Example 1- lB, 2-(3-((5-cyclopropyl-3-(2- (trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4- fluorobenzo[d]thiazole-6-carboxylic acid (20 mg, 0.033 mmol), was suspended in methylene chloride (0.6 mL), cooled to 0 C and treated with Nu,Nu-diisopropylethylamine (aprox. 10 uL, 0.07 mmol) and oxalyl chloride (10 uL, 0.10 mmol). After 20 minutes the reaction was concentrated in vacuo to a reddish colored residue, suspended in THF (0.5 mL) and then treated with 10 N ammonium hydroxide. After 1 hr of stirring, the reaction was diluted with ethyl acetate (1 mL), and water washed (2 x 0.5 mL). The resulting organic extract were concentrated to dryness, re-diluted with MeOH (2 mL), and directly purified using mass-directed reverse phase HPLC, using gradient of 30 to 90 % acetonitrile/water, and 0.05 % TFA as modifier. All product fractions were cold vacuum concentrated and free-based using an SPE polymer support cartridge and MeOH (2 mL) mobilizing solvent (product SPE PLHC03 MP part no PL3540- C603). All resulting methanol effluent was concentrated to furnish the title compound as a white powder, 14 mg (70 %). MS m/z 603.1 (M + 1)., 1383816-29-2

The synthetic route of 1383816-29-2 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; IRM LLC; TULLY, David C.; RUCKER, Paul Vincent; ALPER, Phillip B.; MUTNICK, Daniel; CHIANELLI, Donatella; WO2012/87519; (2012); A1;,
Thiazole | C3H3NS – PubChem
Thiazole | chemical compound | Britannica